Kintsugi

Are you in Las Vegas for HIMSS? Want to see how our AI-powered tool detects signs and severity of depression by analyzing just 20 seconds of free-form speech? We’re giving a demo today at 1:15 PM – 2:15 PM at the Microsoft Pavilion (#2221, Venetian, Level 2). ? See Kintsugi Voice in action, including real-time voice screening for mental health conditions ? Discover how AI-powered voice biomarkers work ? Chat to our team to explore opportunities for collaboration Comment below or send us a message so we can connect! #HIMSS #MentalHealthTech #VoiceAI #MicrosoftPegasus

?? Heading to HIMSS? Come find us at the Microsoft Pavilion! We’re excited to showcase how voice biomarkers are shaping the future of mental health screening. Stop by (#2221, Venetian, Level 2) to see our AI-powered technology in action and chat with our team – including our newest team member, Dana Gusky, Director of Growth Strategy at Kintsugi. ?? Dana brings 10+ years of experience in AI-driven healthcare innovation, clinical decision support and go-to-market strategy – most recently leading business development for life sciences at Aidoc. We're thrilled to have her on board as we scale our impact in mental health tech! And finally, don’t miss Grace Chang, Founder & CEO of Kintsugi, speaking on the Women in Healthcare: Journeys of Leadership and Innovation panel today from 4-5 PM PT at the Microsoft Innovation Theater, alongside Amy Compton-Phillips, MD (Press Ganey) and Edwina Bhaskaran (Mayo Clinic). Let’s connect at #HIMSS25 and talk about the future of mental health innovation! Who’s going? ?? #HIMSS #MentalHealthTech #VoiceAI #MicrosoftPegasus

The future of healthcare is being shaped by bold, innovative women – and we’re excited to be part of the conversation. Grace Chang, Founder & CEO of Kintsugi, will be speaking on the panel Women in Healthcare: Journeys of Leadership and Innovation at the 2025 HIMSS Global Health Conference & Exhibition in Las Vegas. ?? Microsoft Innovation Theater ?? Tuesday, March 4 | 4-5 PM PT Moderated by Kathleen Mitford of Global Industry at Microsoft, this panel brings together women leaders who are driving meaningful change in healthcare. Expect candid conversations on: ?? Breaking barriers in healthtech ?? Lessons from leadership & innovation ?? Navigating challenges & driving impact The panel will be followed by a networking reception, where attendees can connect with executives and industry leaders. See you at #HIMSS25! #MSFTHealth #MicrosoftPartners #PartnersMakeMorePossible #AIInHealthcare #HealthcareOnLinkedIn

?? We’ve got exciting news! Kintsugi has been selected for Microsoft’s Pegasus Program. Among 80,000 startups in Microsoft’s global ecosystem, Kintsugi is one of just a few companies selected for the healthcare track, a recognition of our technology’s potential to reshape mental health care delivery. This partnership is a huge milestone for us as we work to scale our AI-powered voice biomarker platform, which enables early detection of depression and anxiety from as little as 20 seconds of speech. Through Pegasus, we’ll collaborate with Microsoft’s healthcare ecosystem to refine our technology, enhance integration with clinical workflows and expand our impact globally. Read more in our press release at the link below! https://lnkd.in/ePc3yuMb #MentalHealth #VoiceAI

Can AI detect depression from just 25 seconds of speech? Our new research published in The Annals of Family Medicine confirms that Kintsugi’s voice biomarker AI can identify moderate to severe depression with 71% sensitivity – compared to identification rates of just 47.3% in primary care. With depression affecting 21 million Americans each year, yet often going undiagnosed, this breakthrough could help bridge the gap in mental health screening – especially in primary care settings, where routine screening remains rare. AI-powered tools aren’t meant to replace clinical assessments, but they empower clinicians with real-time, objective insights, helping ensure patients get the support they need, when they need it. Read more in Inside Precision Medicine: https://lnkd.in/ezDYQ3zb

With AI as the topic du jour at #vive this week, Fast Company’s Victor Dey explores the evolving role of AI in emotional connection. Grateful to contribute my perspective on how voice AI can support mental health in meaningful ways. As we navigate this space, it’s critical to distinguish between AI as a tool for empowerment versus a replacement for human relationships. Excited to see where this conversation leads! #AI #MentalHealth #VoiceTech #FutureOfAI Full article: https://lnkd.in/gpYqTfHz

Mental health diagnosis and care delivery hasn’t changed much in decades – it still relies heavily on subjective self-reporting, leaving countless patients to slip through the cracks. But what if AI could help change that? In the latest episode of MedTechGurus, host Thomas Hickey sits down with Dr. Prentice Tom, Chief Medical Officer at Kintsugi, to explore how voice biomarker AI is reshaping mental health screening. They discuss: ?? Why traditional mental health assessments are failing patients ?? How voice biomarkers can detect depression and anxiety in new ways ?? How healthcare leaders can address bias and other ethical challenges in AI ?? Why systemic issues – not medical advancements – are the biggest blockers to better care, and how to foster greater innovation to overcome them A must-listen for anyone working in healthcare innovation, AI, or mental health policy. ?? Listen now: https://lnkd.in/es-6T92W

For years, progress toward mental health equity has been slow but steady, with policies like the Mental Health Parity and Addiction Equity Act ensuring that depression and anxiety were treated as central to the lives of millions of Americans. But now, with the potential rollback of this landmark policy, we stand on the brink of losing not just health equity – but also a key driver of American productivity. Depression and anxiety cost the global economy $1 trillion annually in lost productivity, according to the World Health Organization. The potential policy changes could have extreme consequences. But employers have the chance to step into a leadership role. Technology can help them bridge this gap by offering solutions that are both cost-effective and transformative. Here’s why this matters right now: ?? Stigma still exists: Despite progress, many employees hesitate to discuss mental health challenges, fearing judgment or repercussions. Employers need to take this into account and give teams the opportunity to seek support anonymously. ?? Prevention is key: Early identification of mental health issues reduces costs and prevents issues from escalating. ?? Objectivity drives access to care: Just as blood pressure monitors provide clear metrics for physical health, innovative technologies can provide objective insights into mental well-being – eliminating bias and ensuring true parity. As we confront the prospect of diminished federal protections for mental health parity, the real question is not whether we can afford to invest in mental health – it’s whether we can afford not to. https://lnkd.in/gBktBv7v

?? A recent Nature Medicine study highlights that GLP-1 medications like Ozempic and Wegovy could reduce risks of everything from dementia to heart failure. Yet many patients discontinue these treatments within just weeks – well before they experience these benefits. Why? Mental health challenges like depression and anxiety are often hidden barriers to treatment adherence. Making mental health screening a routine part of chronic condition management for diabetes and obesity could: ? Improve mental well-being through timely, appropriate support ? Enhance physical health outcomes, since mental health directly impacts medication adherence AI-powered voice biomarker technology can help bridge this gap by enabling providers to detect signs of mental health struggles early. This ensures patients get the support they need – ultimately improving adherence and helping them realize the full benefits of GLP-1s. https://lnkd.in/einZ7Wyr

?? Kintsugi’s new study on Voice AI is now published in the Annals of Family Medicine! Our peer-reviewed research, conducted in collaboration with UC Berkeley and UAMS, demonstrated that our models can help detect moderate to severe depression with 71.3% sensitivity and 73.5% specificity by analyzing just 25 seconds of free-form speech. With depression screening rates in primary care still below 4%, this technology could be a game-changer for bridging critical gaps in mental health care. ?? Read the full study on the Annals of Family Medicine website! https://lnkd.in/ed-cfs7B #VoiceAI #MentalHealth #VoiceBiomarkers